Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by smush74on Oct 13, 2016 4:42pm
102 Views
Post# 25341174

RE:Can anyone comment on the effect of a new financing on sp

RE:Can anyone comment on the effect of a new financing on sp
If I were you I would wait before putting up any more funds.

1st I don't like averging down (personl style) especially since there has been no new news since their last NR

2nd since the company has said nothing in my opinion it is a risk since we have no clue what the plans going forward will be. Will they need financing who knows?

3rd wait and see what comes out of thier FDA meeting

4th  (I don't thinks this will be the case) they can just shut it down, but too much time and money has been invested time to just close shop.

5th You will have to check up their last PPs but I believe they were lower than what the SP was trading at. I'll assume if they do it at this level or lower you should be able to pick up more if you wish to average down.

But I am biased as most my shares were from BioMS days, and removed from the table my intial position before news/NR was released. Been burned before so more cautious these days.

Josh wish I could be more helpfull, but I just don't have a clue where they want to take this.

Best of luck in your choice
Bullboard Posts